Journal Article

DEXA measures of body fat percentage and acute phase proteins among breast cancer survivors: a Cross-Sectional Analysis

Neuhouser, Marian L, Ballard-Barbash, Rachel, Alfano, Catherine M, Baumgartner, Richard N, McTiernan, Anne, Bernstein, Leslie, Dee, Anne, Ulrich, Cornelia, McKean-Cowdin, Roberta, Baumgartner, Kathy

2012

Overview

Background C-reactive protein (CRP) and Serum amyloid A protein (SAA) increases with systemic inflammation and are related to worse survival for breast cancer survivors. This study examines the association between percent body fat and SAA and CRP and the potential interaction with NSAID use and weight change. Methods Participants included 134 non-Hispanic white and Hispanic breast cancer survivors from the Health, Eating, Activity, and Lifestyle Study. Body fat percentage, measured with Dual Energy X-ray Absorptiometer (DEXA), and circulating levels of CRP and SAA were obtained 30 months after breast cancer diagnosis. Results Circulating concentrations of CRP and SAA were associated with increased adiposity as measured by DEXA after adjustment for age at 24-months, race/ethnicity, dietary energy intake, weight change, and NSAID use. Survivors with higher body fat ≥35% had significantly higher concentrations of CRP (2.01 mg/l vs. 0.85 mg/l) and SAA (6.21 mg/l vs. 4.21 mg/l) compared to non-obese (body fat < 35%). Women who had gained more than 5% of their body weight since breast cancer diagnosis had non-statistically significant higher geometric mean levels of CRP and SAA. Mean levels of CRP and SAA were higher among obese women who were non-users of NSAIDs compared to current users; the association with SAA reached statistical significance (Mean SAA = 7.24, 95%CI 6.13-8.56 for non-NSAID; vs. 4.87; 95%CI 3.95-6.0 for NSAID users respectively). Conclusions Breast cancer survivors with higher body fat had higher mean concentrations of CRP and SAA than women with lower body fat. Further assessment of NSAID use and weight control in reducing circulating inflammatory markers among survivors may be worthwhile to investigate in randomized intervention trials as higher inflammatory markers are associated with worse survival.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Absorptiometry, Photon / Acute phase proteins / Acute-Phase Proteins - analysis / Adipose Tissue - physiology / Adipose tissues / Adult / Aged / Analysis / Biomedical and Life Sciences / Biomedicine / Body fat / Body mass index / Body weight / Breast cancer / Breast Neoplasms - chemistry / Breast Neoplasms - pathology / Cancer Research / Cancer survivors / Cross-Sectional Studies / Epidemiology / Family medical history / Female / Health aspects / Health care / Health Promotion and Disease Prevention / Health sciences / Health services / Hispanic people / Humans / Inflammation / Lifestyles / Linear Models / Measurement / Medical research / Medicine/Public Health / Middle Aged / Obesity / Oncology / Proteins / Public health / Research Article / Surgical Oncology / Surveys and Questionnaires / Survivors - statistics & numerical data / United States / Weight control / Womens health